Genome Pharmaceuticals Sets Up Research Team | GenomeWeb

MUNICH--Genome Pharma ceuticals, a genomics-based drug discovery company here, announced the appointment of Zoltan Nagy as vice-president of immunology. Nagy previously held positions as a scientific member of the Basel Institute of Immunology, deputy director of the Max Planck Institute for Biology, project leader in preclinical research at Novartis, and most recently as department head of immunology at Hoffmann-La Roche.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.